Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers

Fig. 3

Ascites levels of inflammation-regulating factors in clinically resistant patients and those sensitive to first-line treatment. Box plots representing ascites levels of IL-6 (a), IL-10 (b), suPAR (c), serum CA125 (d), OPG (e), CCL18 (f) and leptin (g) in patients with resistance to first-line therapy and patients with sensitive diseases. The P value is indicated for each factor. ROC analysis using the combination of CA125/leptin and CA125/suPAR (h) and CA125/IL-6 (i) for distinguishing patients with resistant or sensitive EOC

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us